February 25, 2020 / 6:58 PM / a month ago

BRIEF-Unity Biotechnology Says First-In-Human Study Initiation For Ophthalmology Program Expected In H2 2020

Feb 25 (Reuters) - UNITY Biotechnology Inc:

* UNITY BIOTECHNOLOGY - PHASE 2 STUDY OF UBX0101 IN PATIENTS WITH OSTEOARTHRITIS HAS COMPLETED ENROLLMENT

* UNITY BIOTECHNOLOGY - TOPLINE 12- AND 24-WEEK RESULTS FOR PHASE 2 STUDY OF UBX0101 NOW EXPECTED IN H2 2020

* UNITY BIOTECHNOLOGY - FIRST-IN-HUMAN STUDY INITIATION FOR OPHTHALMOLOGY PROGRAM EXPECTED IN 2H 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below